Abstract:Objective Lectin-like Ox-LDL receptor-1 (LOX-1), a novel vascular receptor for oxidized LDL, is responsible for recognition and internalization of ox-LDL in vascular cells. It also mediates a spectrum of pro-atherogenic cellular responses implicated in the development and progression of atherosclerosis including endothelial dysfunction and apoptosis, vascular inflammation, foam cell formation and collagen deposition. Previous studies revealed that expression of LOX-1 was highly inducible by proinflammatory stimuli, such as tumor necrosis factor-alpha (TNF-α), Ox-LDL and lipopolysaccharide (LPS). We have demonstrated that tanshinone II-A (a diterpene flavonoids isolated from Tanshen) supplementation retarded the atherogenesis progression in ApoE knockout mice via inhibition of LOX-1 expression. Therefore, we hypothesized that tanshinone II-A could also inhibit LOX-1 expression induced by pro-inflammatory stimuli in murine macrophages. Design and Methods RAW264.7 cells and murine peritoneal macrophages were cultured. Quantitative real-time PCR and western blot were used to determine LOX-1 gene and protein expression. Electrophoretic mobility shift assay (EMSA) was performed to demonstrate the nuclear protein binding to NF-κB regulatory element of LOX-1 gene. Results Pretreatment of cultured macrophages with tanshinone II-A inhibited LOX-1 expression induced by Ox-LDL at both protein and mRNA levels in a time- and concentration-dependent manner. The inhibitory effect was also observed in the cells treated with antioxidants or inhibitors of nuclear factor-kappaB (NF-κB). The activation of NF-κB and phosphorylation of inhibitory factor of NF-kappaB-α (IκB-α) induced by Ox-LDL were suppressed by tanshinone II-A in a time- and concentration-dependent fashion. Ox-LDL also enhanced the binding of nuclear protein to NF-κB regulatory element of LOX-1 gene promoter. This effect was abrogated by tanshinone II-A. Furthermore, the DiI-Ox-LDL uptake study demonstrated that tanshinone II-A concentration-dependently diminished Ox-LDL uptake by macrophages. Conclusions Tanshinone II-A suppressed Ox-LDL-induced LOX-1 expression and the subsequent macrophage foam cell formation, by inhibiting NF-κB activation and ROS generation.

Astaxanthin suppresses End MT by LOX-1 pathway in ox-LDL-induced HUVECs

siLOXL2 Inhibits Endothelial Inflammatory Response and EndMT Induced by ox-LDL

Inhibition of Superoxide Anion-Mediated Impairment of Endothelium by Treatment with Luteolin and Apigenin in Rat Mesenteric Artery.

Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism

Astaxanthin Alleviates Hepatic Lipid Metabolic Dysregulation Induced by Microcystin-LR

Tongxinluo Attenuates Atherosclerosis by Inhibiting ROS/NLRP3/caspase-1-mediated Endothelial Cell Pyroptosis.

Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2

Oxidative Stress Regulation on Endothelial Cells by Hydrophilic Astaxanthin Complex: Chemical, Biological, and Molecular Antioxidant Activity Evaluation

Overexpression of sFlt-1 represses ox-LDL-induced injury of HUVECs by activating autophagy via PI3K/AKT/mTOR pathway

Tanshinone II-A Inhibited Oxidized Low-Density-Lipoprotein Induced LOX-1 Expression in Murine Macrophages by Reduction of Intracellular Reactive Oxygen Species (ROS) and NF-KappaB Activation

H2 inhibits TNF-α-induced lectin-like oxidized LDL receptor-1 expression by inhibiting nuclear factor κB activation in endothelial cells

Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt

The protective effects of annexin A1 against oxidized-LDL-induced monocytes adhesion to endothelial cells: implication in atherosclerosis

Astaxanthin Induces the Nrf2/HO-1 Antioxidant Pathway in Human Umbilical Vein Endothelial Cells by Generating Trace Amounts of ROS

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

Astaxanthin From Haematococcus pluvialis Prevents High-Fat Diet-Induced Hepatic Steatosis and Oxidative Stress in Mice by Gut-Liver Axis Modulating Properties

HRD1 prevents atherosclerosis-mediated endothelial cell apoptosis by promoting LOX-1 degradation

Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-κB-mediated inflammation in high fructose and high fat diet-fed mice

Activation of the Nrf2/HO-1 axis by glutaredoxin 2 overexpression antagonizes vascular endothelial cell oxidative injury and inflammation under LPS exposure

Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid